Dr. Klamerus served as the president and medical director of the McLaren Cancer Institute from 2012-2014; and cancer program director at McLaren Northern Michigan from 2009-2012, where he also practiced medical oncology. At McLaren, Dr. Klamerus lead cancer research operations, serving as principal investigator for cancer research. During his tenure, McLaren saw a four-fold increase in cancer research accruals.
Dr. Klamerus is a graduate of the College of Human Medicine at Michigan State University. He completed his residency and chief residency in Internal Medicine at The Ohio State University in Columbus, Ohio. He also served as a clinical instructor of Internal Medicine and as a lecturer in the College of Medicine and Public Health at Ohio State. Following his time at Ohio State, he attended Johns Hopkins University where he completed a fellowship in Medical Oncology. Dr. Klamerus earned a Master of Medical Management degree in the Heinz College at Carnegie Mellon University. Currently, he is completing a management fellowship in health system leadership in the General Electric Leadership Fellowship program of the Health Management Academy.
Ad Statistics
Times Displayed: 125799
Times Visited: 7246 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Dr. Klamerus is a member of the American Society of Clinical Oncology, having served on several committees including the Clinical Practice and the Government Relations Committees. He is also a member of the Steering Committee of the Michigan Oncology Quality Consortium. Dr. Klamerus has served as the Program Director of the Michigan Oncology Clinical Treatment Pathways Program, a clinical quality initiative of Blue Cross Blue Shield of Michigan.
He is board certified in medical oncology and internal medicine. His published works include the book, "The Johns Hopkins Patient Guide to Lung Cancer," and several papers on access to cancer clinical trials, health care disparities and cancer care delivery.
About the Barbara Ann Karmanos Cancer Institute
Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute, a subsidiary of McLaren Health Care, is one of 47 National Cancer Institute-designated comprehensive cancer centers in the United States. Karmanos is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteer and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. Its long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. Gerold Bepler, M.D., Ph.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to www.karmanos.org.
SOURCE Karmanos Cancer Institute
Back to HCB News
